Radiocontrast-induced nephropathy (RCIN) is a common and potentially serious complication following diagnostic and therapeutic cardiology procedures using radiocontrast media. The first and most important step in reducing the likelihood of RCIN is to identify patients at risk, by medical history and measurement of serum creatinine concentration to allow calculation of estimated glomerular filtration rate (GFR). Extracorporeal blood purification effectively removes radiocontrast media from the circulation. Periprocedural extracorporeal blood purification (hemodialysis or continuous renal replacement therapy) does not reduce the incidence of RCIN compared with standard medical therapy, and cannot be recommended at this time. The potential benefit of continuous venovenous hemofiltration published by a single center should be confirmed with further studies before it can be recommended or disregarded, and higher doses of continuous renal replacement therapy may also merit further investigation.
FinnW.F.. The clinical and renal consequences of contrast-induced nephropathy.Nephrol Dial Transplant2006; 21(Suppl): i2–10.
3.
RihalC.S., TextorS.C., GrillD.E., BergerP.B., TingH.H., BestP.J., SinghM., BellM.R., BarsnessG.W., MathewV., GarrattK.N., HolmesD.R.Jr.. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.Circulation2002; 105: 2259–64.
4.
McColloughP.A., WolynR., RocherL.L., LevinR.N., O'NeillW.W.. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.Am J Med1997; 103: 368–75.
5.
SadeghiH.M., StoneG.W., GrinesC.L., MehranR., DixonS.R., LanskyA.J., FahyM., CoxD.A., GarciaE., TchengJ.E., GriffinJ.J., StuckeyT.D., TurcoM., CarrollJ.D.. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.Circulation2003; 108: 2769–75.
6.
DangasG., IakovouI., NikolskyE., AymongE.D., MintzG.S., KipshidzeN.N., LanskyA.J., MoussaI., StoneG.W., MosesJ.W., LeonM.B., MehranR.. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.Am J Cardiol2005; 95: 13–9.
7.
American Heart Association.Heart disease and stroke statistics update:American Heart Association, 2005.
8.
TogniM., BalmerF., PfiffnerD., MaierW., ZeiherA.M., MeierB.; Working Group, Interventional Cardiology and Coronary Pathophysiology, European Society of Cardiology. Percutaneous coronary interventions in Europe 1992–2001.Eur Heart J2004; 25: 1208–13.
GrubergL., MintzG.S., MehranR., GangasG., LanskyA.J., KentK.M., PichardA.D., SatlerL.F., LeonM.B.. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.J Am Coll Cardiol2000; 36: 1542–8.
11.
TumlinJ., StaculF., AdamA., BeckerC.R., DavidsonC., LameireN., McCulloughP.A.; CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy.Am J Cardiol2006; 98(Suppl): 14K–20.
12.
LameireN., AdamA., BeckerC.R., DavidsonC., McCulloughP.A., StaculF., TumlinJ.; CIN Consensus Working Panel. Baseline renal function screening.Am J Cardiol2006; 98(Suppl): 21K–26.
13.
LeveyA.S., BoschJ.P., LewisJ.B., GreeneT., RogersN., RothD.; for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.Ann Intern Med1999; 130: 461–70.
14.
ChoykeP.L., CadyJ., DePollarS.L., AustinH.. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?Tech Urol1998; 4: 65–9.
15.
GlauserJ., MontgomeryA.. Urine protein as a rapid screen for renal function in the ED.can it replace serum creatinine in selected patients? Emerg Radiol2004; 10: 319–22.
McCulloughP.A., SomanS.S.. Contrast-induced nephropathy.Crit Care Clin2005; 21: 261–80.
18.
MertenG.J., BurgessW.P., GrayL.V.. Prevention of contrast induced nephropathy with sodium bicarbonate: a randomized controlled trial.JAMA2004; 291: 2328–34.
19.
SaldinR., ZalnudinS., KongN., MaskonO., SaaidinN., ShahS.. Intravenous sodium bicarbonate versus normal saline as prophylaxis against contrast nephropathy in patients with chronic kidney disease undergoing coronary angiography or angioplasty.http://www.abstracts2view.com/asn/view.php?nu=ASN06L1_2088a. Accessed Nov, 2006.
20.
FromA.M., BartholmaiB.J., WilliamsA.W., ChaS.S., PfluegerA., McDonaldF.S.. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at Mayo Clinic.Clin J Am Soc Nephrol2008; 3: 10–8.
21.
AlonsoA., LauJ., JaberB.L., WeintraubA., SarnakM.J.. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a metaanalysis of randomized controlled trials.Am J Kidney Dis2004; 43: 1–9.
22.
IxJ.H., McCullochC.E., ChertowG.M.. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis.Nephrol Dial Transplant2004; 19: 2747–53.
23.
MuellerC.. Prevention of contrast-induced nephropathy with volume supplementation.Kidney Int Suppl2006; 100: S16–9.
24.
BriguoriC., MarenziG.. Contrast-induced nephropathy: pharmacological prophylaxis.Kidney Int Suppl2006; 100: S30–8.
25.
BaarsH.G., SchabelJ., WeissM.. Contrast medium elimination by hemodialysis.Z Urol Nephrol1984; 77: 473–81.
26.
KierdorfH., KindlerJ., WinterscheidR.. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.RÖFO1989; 128(Suppl): S119–23.
27.
DonnellyP.K., BurwellN., McBurneyA., WardJ.W., WallsJ., WatkinEM. Hemodialysis and iopamidol clearance after subclavian venography.Invest Radiol1993; 28: 629–32.
28.
MoonS.S., BackS.E., KurkusJ.. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function.Nephron1995; 70: 430–7.
29.
UedaJ., FurukawaT., HigashinoK.. Elimination of iomeprol by hemodialysis.Eur J Radiol1996; 23: 197–200.
30.
UedaJ., FurukawaT., TakahashiS., SakaguchiK.. Elimination of ioversol by hemodialysis.Acta Radiol1996; 37: 826–9.
31.
FurukawaT., UedaJ., TakahashiS., SakaguchiK.. Elimination of low-osmolality contrast media by hemodialysis.Acta Radiol1996; 37: 966–71.
32.
LehnertT., KellerE., GondolfK., SchaffnerT., PavenstadtH., SchollmeyerP.. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.Nephrol Dial Transplant1998; 13: 358–62.
33.
MatzkiesF.K., TombachB., KistersK.. Clearance of iopromide during haemodialysis with high- and low-flux membranes.Acta Radiol1999; 40: 220–3.
34.
MatzkiesF.K., ReineckeH., TombachB.. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.Am J Nephrol2000; 20: 300–4.
35.
MatzkiesF.K., ReineckeH., TombachB., KoenekeJ., HohageH., KistersK., SchaeferR.M.. Reduced iopromide elimination in hemodialysis with cuprophan membranes.Acta Radiol2000; 41: 671–3.
36.
SternerG., FrennbyB., KurkusJ., NymanU.. Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy?Scand J Urol Nephrol2000; 34: 323–6.
37.
LorussoV., TaroniP., AlvinoS.. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.Invest Radiol2001; 36: 309–16.
38.
BergerE., BaderB., BoskerJ., RislerT., ErleyC.. Contrast media-induced kidney failure cannot be prevented by hemodialysis.Dtsch Med Wochenschr2001; 126: 162–6.
39.
SchindlerR., StahlC., VenzS., LudatK., KrauseW., FreiU.. Removal of contrast media by different extracorporeal treatments.Nephrol Dial Transplant2001; 16: 1471–74.
40.
FrankH., WernerD., LorussoV.. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.Clin Nephrol2003; 60: 176–82.
41.
GabuttiL., MaroneC., MontiM.. Does continuous venovenous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol?Blood Purif2003; 21: 152–7.
OkahisaT., SogabeM., HayashiS., ShibataH., ItoS.. Contrast medium-removing effect of hemofiltration and hemodiafiltration.J Med Invest1998; 45: 87–93.
44.
HuberW., JeschkeB., KreymannB.. Haemodialysis for the prevention of contrast-induced nephropathy.Invest Radiol2002; 37: 471–81.
45.
CruzD., PerazellaM., BellomoR., CorradiV., de CalM., KuangD., OcampoC., NalessoF., RoncoC.. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review.Am J Kidney Dis2006; 48: 361–71.
46.
VogtB., FerrariP., SchonholzerC.. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.Am J Med2001; 111: 692–8.
47.
MarenziG., MaranaI., LauriG.. The prevention of radio-contrast-agent-induced nephropathy by hemofiltration.N Engl J Med2003; 349: 1333–40.
48.
MarenziG., LauriG., CampodonicoJ, MaranaI.. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.Am J Med2006; 119: 155–62.
49.
HsiehY.C., TingC.T., LiuT.J., WangC.L., ChenY.T., LeeW.L.. Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency.Int J Cardiol2005; 101: 407–13.
50.
StaculF., AdamA., BeckerC.R., DavidsonC., LameireN., McCulloughP.A., TumlinJ.; CIN Consensus Working Panel. Strategies to reduce the risk of contrast-induced nephropathy.Am J Cardiol2006; 98(Suppl): 59K–77.
51.
RoncoC., BellomoR., HomelP.. Effects of different doses in continuous venovenous hemofiltration on outcomes of acute renal failure.Lancet2000; 356: 20–30.
52.
FormanJ.. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy (letter).N Engl J Med2004; 350: 837.
53.
SelaS., Shurtz-SwirskiR., ShapiroG.. Oxidative stress during hemodialysis: effect of heparin.Kidney Int Suppl2001; 78: S159–63.
54.
HanW.K., BaillyV., AbichandaniR., ThadhaniR., BonventreJ.V.. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.Kidney Int2002; 62: 237–44.
55.
MuramatsuY., TsujieM., KohdaY.. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury.Kidney Int2002; 62: 1601–10.
56.
MishraJ., DentC., TarabishiR.. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.Lancet2005; 365: 1231–8.
